Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 9
2003 7
2004 4
2005 3
2006 3
2007 2
2008 3
2009 1
2010 5
2011 5
2012 4
2013 3
2014 1
2015 1
2016 1
2017 1
2018 2
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Huntington's disease.
Bonelli RM, Beal MF. Bonelli RM, et al. Handb Clin Neurol. 2012;106:507-26. doi: 10.1016/B978-0-444-52002-9.00030-9. Handb Clin Neurol. 2012. PMID: 22608641 Review. No abstract available.
Sexuality in Huntington's disease.
Schmidt EZ, Bonelli RM. Schmidt EZ, et al. Wien Med Wochenschr. 2008;158(3-4):78-83. doi: 10.1007/s10354-007-0477-8. Wien Med Wochenschr. 2008. PMID: 18330523 Review.
There are just a few studies in literature about sexuality in Huntington's disease which conclude that up to 85% men and up to 75% of women experience high levels of sexual problems, most of them having prevalent symptoms of a hypoactive sexual disorder but also increased …
There are just a few studies in literature about sexuality in Huntington's disease which conclude that up to 85% men and up to 75% of …
Frontal-subcortical dementias.
Bonelli RM, Cummings JL. Bonelli RM, et al. Neurologist. 2008 Mar;14(2):100-7. doi: 10.1097/NRL.0b013e31815b0de2. Neurologist. 2008. PMID: 18332839 Review.
Classic frontal-subcortical dementias include Huntington chorea, Parkinson disease dementia, progressive supranuclear palsy, thalamic degeneration, subcortical vascular dementia, multiple sclerosis, the acquired immunodeficiency syndrome dementia complex, depressive pseudo …
Classic frontal-subcortical dementias include Huntington chorea, Parkinson disease dementia, progressive supranuclear palsy, thalamic …
Olanzapine-associated seizure.
Bonelli RM. Bonelli RM. Ann Pharmacother. 2003 Jan;37(1):149-50. doi: 10.1345/aph.1C288. Ann Pharmacother. 2003. PMID: 12503952 No abstract available.
Reversible Huntington's disease?
Bonelli RM, Költringer P, Kenner L, Reisecker F. Bonelli RM, et al. Lancet. 1998 Nov 7;352(9139):1520-1. doi: 10.1016/s0140-6736(05)60326-1. Lancet. 1998. PMID: 9820304 No abstract available.
Huntington's disease: present treatments and future therapeutic modalities.
Bonelli RM, Wenning GK, Kapfhammer HP. Bonelli RM, et al. Int Clin Psychopharmacol. 2004 Mar;19(2):51-62. doi: 10.1097/00004850-200403000-00001. Int Clin Psychopharmacol. 2004. PMID: 15076012 Review.
Huntington's disease (HD) is a devastating neuropsychiatric disorder for which therapeutic interventions have been rather fruitless to date, except in a slight symptomatic relief. ...
Huntington's disease (HD) is a devastating neuropsychiatric disorder for which therapeutic interventions have been rather fruitless t …
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators; Holmans P, Jones L, Tabrizi SJ. Moss DJH, et al. Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642124
BACKGROUND: Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis looking for Huntington's disease modifiers, but is hard to define and not always available. . …
BACKGROUND: Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. Age at onset has been used as a qua …
A review of the treatment options for Huntington's disease.
Bonelli RM, Hofmann P. Bonelli RM, et al. Expert Opin Pharmacother. 2004 Apr;5(4):767-76. doi: 10.1517/14656566.5.4.767. Expert Opin Pharmacother. 2004. PMID: 15102562 Review.
Huntington's disease (HD) is an autosomal dominant, inherited, neuropsychiatric disease which gives rise to progressive motor, cognitive and behavioural symptoms. ...
Huntington's disease (HD) is an autosomal dominant, inherited, neuropsychiatric disease which gives rise to progressive motor, cognit …
Frontal-subcortical circuitry and behavior.
Bonelli RM, Cummings JL. Bonelli RM, et al. Dialogues Clin Neurosci. 2007;9(2):141-51. doi: 10.31887/DCNS.2007.9.2/rbonelli. Dialogues Clin Neurosci. 2007. PMID: 17726913 Free PMC article. Review.
A variety of other neuropsychiatric disorders, such as Tourette's syndrome, Huntington's disease, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, schizophrenia, and mood disorders may result from disturbances that have a direct or indirect impact o …
A variety of other neuropsychiatric disorders, such as Tourette's syndrome, Huntington's disease, obsessive-compulsive disorder, atte …
Pharmacological management of Huntington's disease: an evidence-based review.
Bonelli RM, Wenning GK. Bonelli RM, et al. Curr Pharm Des. 2006;12(21):2701-20. doi: 10.2174/138161206777698693. Curr Pharm Des. 2006. PMID: 16842168 Review.
INTRODUCTION: Despite the increasing body of published reports on pharmacological interventions in Huntington's disease (HD), an evidence based review (EBR) of treatment studies has not yet been published. ...
INTRODUCTION: Despite the increasing body of published reports on pharmacological interventions in Huntington's disease (HD), an evid …
54 results